Products
| Molecule name | Ingredients | Therapy | Innovator & Brand | Territories where the product is registered | Territories where the Product is under Registration | Future Target Market |
|---|---|---|---|---|---|---|
| Amlodipine tablets | Amlodipine Besylate | Anti-Hypertensive | Pfizer - Istin | Germany, Portugal, Austria, Spain, Ireland, Malta, Poland, UK |
Philippines, Vietnam | Canada, GCC, Australia, USA |
| Azithromycin capsules | Azithromycin | Anti-infective | Pfizer- Zithroma | UK | Philippines, Vietnam, FWA | EU, Canada, Australia, GCC, USA |
| Carbidopa + Levodopa ER tablets | Carbidopa and Levodopa | Parkinson's disease | Merck & Dohme– SINEMET CR Impax Laboratories –RYTARY |
- | Guatemala, Nicaragua, Costa Rica, Honduras, UK, Ukraine, Zazibona | EU, Canada and Australia |
| Carbidopa + Levodopa IR tablets | Carbidopa and Levodopa | Parkinson's disease | Merck & Dohme– SINEMET Merck & Dohme– SINEMET PLUS |
Malta, UK, Czechia, Denmark, Canada, Australia, Germany, Spain, Poland, New Zealand, Vietnam, Paraguay |
Philippines, Myanmar, Nicaragua, Honduras,Panama, Guatemala, Nicargua, Costa Rica, Hondurus, EI Salvador |
GCC, USA |
| Cetirizine tablets | Cetirizine | Anti-histamine | UCB – ZYRTEC | Germany, Malta, Poland, Australia, Canada, UK, Vietnam, Portugal |
- | GCC, USA |
| Levocetirizine tablets | Levocetirizine | Anti-histamine | UCB – XYZAL | Germany, Poland, UK Malta, Portugal |
Australia, Chile | EU, Canada, GCC, UK, USA |
| Olmesartan tablets | Olmesartan Medoxomil | Anti-Hypertension | Daiichi Sankyo – OLMETEC | - | Philippines, Myanmar, Vietnam, Ukraine | EU, Canada, Australia, GCC, UK, USA |
| Olmesartan + HCTz tablets | Olmesartan Medoxomil and Hydrochlorothiazide | Anti-Hypertension | Daiichi Sankyo - Co Olmetec Daiichi Sankyo - Benicar HCT Daiichi Sankyo - Olmetec Plus |
- | Philippines, Myanmar, Vietnam | EU, Canada, Australia, GCC, UK, USA |
| Raloxifene tablets | Raloxifene | Osteoporosis | Daiichi Sankyo – EVISTA | UK, Spain | Philippines, Myanmar, Vietnam | Canada, Australia, GCC, USA |
| Telmisartan tablets | Telmisartan | Anti-Hypertension | Boehringer Ingelheim – MICARDIS | Australia, Ireland, UK, Malta, Czech Republic, Germany, Spain, Hungary, Netherlands, Poland, Romania, Philipines, Slovakia, Peru, Paraguay | Trinidad and Tobago, Guyana, Jamaica, GCC | Canada, Australia, USA |
| Telmisartan Amlodipine tablets | Telmisartan and Amlodipine Besylate | Anti-Hypertension | Boehringer Ingelheim – TWYNSTA | Australia, Vietnam, Philippines, Ukraine, Peru, UAE, Hungary | Malaysia, Zazibona, Paraguay, Myanmar, Nicaragua, Honduras, UK | Canada, EU, GCC, USA |
| Telmisartan + HCTz tablets | Telmisartan and Hydrochlorothiazide | Anti-Hypertension | Boehringer Ingelheim - MICARDIS PLUS | Australia, Philippines, Vietnam, Peru | Guyana, Trinidad and Tobago, Myanmar, Paraguay, UK, Jamaica | Canada, EU, GCC, USA |
| Metformin IR tablets | Metformin IR | Anti-Diabetic | Merck - Glucopage | - | UK, Philippines | - |
| Paraoxetine | Paroxetine | Anti Depressant | Seroxat GSK | UK | Vietnam | - |
Products in the pipeline
| Molecule name | Ingredients | Therapy | Current Stage of Development | Dossier Availability |
|---|---|---|---|---|
| Clopidogrel tablets | Clopidogrel Bisulphate | Anti-Platelet | BE Study Scheduled in Q2CY24 | Q2CY24 |
| Hydroxyzine Hydrochloride tablets | Hydroxyzine Hydrochloride | Anti-Histamine | R&D in progress | Q3CY24 |
| Montelukast + Levocetrizine tablets | Montelukast, Levocetirizine | Anti-Histamine | R&D in progress | Q4CY24 |
| Apixaban Tablet | Apixaban | Anti-Platelet | Complete dossier without BE study available, BE study scheduled before April 2024 | Q3CY24 |
| Dimethyl Fumarate Capsule | Dimethyl Fumarate | Immunomodulators | Complete dossier without BE study available, BE study scheduled before June 2024 | Q3CY24 |
| Esomeprazole Delayed Release Tablets | Esomeprazole | PPI's | R&D in progress | Q1CY25 |